PI3K-Akt-mTOR is often dysregulated and overactivated in cervical cancer due to various genetic mutations, including PTEN depletion, PI3KCA mutation and sustained activation or mutation of multiple receptor tyrosine kinases (RTKs) 63-65. This evidence concerns the gene NTRK1 and cervical cancer.